These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2898576)

  • 21. [Effect of troxerutin on platelet aggregation in patients with arteriosclerosis].
    Myśliwiec M; Bodzenta A
    Pol Tyg Lek; 1983 Oct; 38(44):1367-8. PubMed ID: 6674961
    [No Abstract]   [Full Text] [Related]  

  • 22. New pharmacological and clinical properties of the venoactive agent: Venoruton (Paroven). Studies presented at the 1st Mediterranean Congress of Angiology. Corfu, Greece, May 29 to June 3, 1988. Abstracts.
    Int Angiol; 1988; 7(4 Suppl):1-16. PubMed ID: 3249081
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardioprotective properties of O-(beta-hydroxyethyl)-rutosides in doxorubicin-pretreated BALB/c mice.
    van Acker SA; Voest EE; Beems DB; Madhuizen HT; de Jong J; Bast A; van der Vijgh WJ
    Cancer Res; 1993 Oct; 53(19):4603-7. PubMed ID: 8402634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of sudden deafness of vascular etiology with venoruton].
    Madej S
    Otolaryngol Pol; 1989; 43(3):214-7. PubMed ID: 2695884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rutoside and the X-ray induced damage in jejunal mucosa of mouse.
    Rao KR; Fritz-Niggli H
    Strahlentherapie; 1984 Oct; 160(10):624-6. PubMed ID: 6388050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. o-(beta-Hydroxyethyl)-rutoside-mediated protection of renal injury associated with cis-diamminedichloroplatinum(II)/hyperthermia treatment.
    Bull JM; Strebel FR; Sunderland BA; Bulger RE; Edwards M; Siddik ZH; Newman RA
    Cancer Res; 1988 Apr; 48(8):2239-44. PubMed ID: 3349489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Venoruton and capillary permeability].
    Cesarone MR; Laurora G; Gabini M; Errichi BM; Candiani C; Belcaro G
    Minerva Cardioangiol; 1989 May; 37(5):265-8. PubMed ID: 2779806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of hydroxyethylrutosides (HR): metabolism of [14C]-HR in man.
    Hackett AM; Griffiths LA; Luyckx AS; van Cauwenberge H
    Arzneimittelforschung; 1976; 26(5):925-8. PubMed ID: 989368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of capillary permeability and microcirculation in patients with chronic venous hypertension treated with venoruton by the vacuum suction chamber (VSC) device and laser-Doppler flowmetry.
    Belcaro G; D'Aulerio A; Rulo A; Candiani C
    Phlebologie; 1988; 41(4):847-56. PubMed ID: 3073400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of oxygen-derived free radical scavengers on the endothelium in vivo.
    Hladovec J
    Physiol Bohemoslov; 1986; 35(2):97-103. PubMed ID: 2941813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of two venotropic drugs on inactivation and O-methylation of catecholamines in an isolated canine vein.
    Araújo D; Gulati O; Osswald W
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):192-202. PubMed ID: 4062437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HPLC determination of troxerutin in plasma and urine following oral administration in man].
    Dittrich P; Ostrowski J; Beubler E; Schraven E; Kukovetz W
    Arzneimittelforschung; 1985; 35(4):765-7. PubMed ID: 4015744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of O-(beta-hydroxyethyl)-rutoside or venoruton on lactate dehydrogenase of human cultured varicose veins.
    Matagne D; Hamoir G
    Biochem Pharmacol; 1975 Aug; 24(16):1491-4. PubMed ID: 1191306
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prevention of radiation-induced skin reactions in breast cancer].
    Pischnamazzadeh M
    Strahlentherapie; 1983 Jan; 159(1):9-12. PubMed ID: 6340249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of O-(beta-hydroxyethyl)-rutosides (HR) on the skin capillary resistance of rats.
    Gábor M
    Arzneimittelforschung; 1981; 31(3):442-5. PubMed ID: 7194669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of Venoruton on the lower-leg volume in normal persons and in patients with venous-flow disorders].
    Bopp J
    Med Welt; 1977 Oct; 28(41):1660-4. PubMed ID: 927128
    [No Abstract]   [Full Text] [Related]  

  • 37. Analgesic effect of O-(beta-hydroxy ethyl)rutoside in mice.
    Ramaswamy S; Pillai NP; Gopalakrishnan V; Parmar NS; Ghosh MN
    Indian J Exp Biol; 1985 Apr; 23(4):219-20. PubMed ID: 4077117
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of O-(beta-hydroxyethyl)-rutoside (HR) on macromolecular leakage, thrombosis and haemostasis in experimental animals.
    Bergqvist D; Svensjö E; Arfors KE
    Ups J Med Sci; 1978; 83(2):123-7. PubMed ID: 664118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A possible participation of gonadotropin-releasing hormone in the neuroleptic and cataleptic effect of haloperidol.
    Umathe SN; Wanjari MM; Manna SS; Jain NS
    Neuropeptides; 2009 Jun; 43(3):251-7. PubMed ID: 19403167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of troxerutin and methionine on spin trapping of free oxy-radicals.
    Blasig IE; Loewe H; Ebert B
    Biomed Biochim Acta; 1988; 47(10-11):S252-5. PubMed ID: 2907855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.